JPRN-UMIN000026244已完成未知
Single-center, open-label exploratory study to assess the efficacy and safety of TSUMURA Kamikihito Extract Granules for Ethical Use (TJ-137) for the treatment of anxiety in patients with chronic constipation syndrome - Exploratory study to assess the efficacy and safety of TJ-137 for the treatment of anxiety in patients with chronic constipation syndrome
Kobayashi Medical Clinic Tokyo0 个研究点目标入组 25 人开始时间: 2017年2月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients who meet any of the following criteria will be excluded from the study: 1. has taken prohibited concomitant medication within two weeks before the start of study; 2. has changed the dose and administration of restricted concomitant medication within two weeks before the start of study; 3. requires a new medication during the study other than the study drug; 4. has serious complications (liver, kidney, heart, and blood disorders or metabolic and psychiatric disorders); 5. is pregnant, breast-feeding or possibly pregnant women; 6. is otherwise deemed ineligible by the study investigator.
研究者
相似试验
进行中（未招募）
不适用
Single center, exploratoric, open-label study to investigate the precise mechanism of action of Cavinton (vinpocetin)endothel dysfunction and peripherial circulationEUCTR2006-004641-42-HUGedeon Richter Plc
进行中（未招募）
不适用
Single center, exploratoric, open-label study to investigate the add-on effect of vinpocetin to the haemorheological effect of 100 mg acetyl-salicylicum in patients with chronic cerebrovascular diseaseAspirin resistance in patients with chronic cerebrovascular diseaseMedDRA version: 9.1Level: LLTClassification code 10045652Term: Unspecified cerebrovascular diseaseEUCTR2008-001835-36-HUGedeon Richter Plc.
已完成
不适用
An open label, single center study to investigate the metabolic profile of dalcetrapib after a single oral dose in healthy male subjectscoronary heart disease10011082NL-OMON35295F. Hoffmann-La Roche Ltd.6
已完成
不适用
Single-Center, Open-label Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-radio-labeled RO4602522 in Healthy Male Volunteers10029305Alzheimer's diseasedementiaNL-OMON36882Hoffmann-La Roche6
已完成
不适用
Single center, open-label study investigating the excretion balance, pharmacokinetics and metabolism of a single oral dose of [14C]-labeled RO6889450 in healthy male volunteers10039628SchizophreniaNL-OMON51079F. Hoffman-La Roche Ltd6